Cambridge Trust’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.13K Hold
32
﹤0.01% 638
2023
Q4
$947 Hold
32
﹤0.01% 671
2023
Q3
$665 Hold
32
﹤0.01% 697
2023
Q2
$785 Hold
32
﹤0.01% 681
2023
Q1
$1.3K Hold
32
﹤0.01% 732
2022
Q4
$1K Hold
32
﹤0.01% 790
2022
Q3
$2K Hold
32
﹤0.01% 795
2022
Q2
$2K Hold
32
﹤0.01% 814
2022
Q1
$4K Hold
32
﹤0.01% 838
2021
Q4
$5K Buy
+32
New +$4.32K ﹤0.01% 899

Other funds holding TNDM

Cambridge Trust's TNDM Position: Q1 2024 in Review

Cambridge Trust held its Tandem Diabetes Care (TNDM) position steady in Q1 2024 at 32 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #638.

Cambridge Trust first reported a position in TNDM in Q4 2021 and has held it in 10 quarters since. The position peaked at $5K in Q4 2021. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • Cambridge Trust held 32 shares of Tandem Diabetes Care worth $1.13K as of Q1 2024.
  • Cambridge Trust left its Tandem Diabetes Care share count unchanged in Q1 2024.
  • Tandem Diabetes Care made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #638 holding.
  • Cambridge Trust first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 10 quarters since.
  • Cambridge Trust's Tandem Diabetes Care position peaked at $5K in Q4 2021.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.